Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Graham

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
Cardiology and Therapy|August 20, 2014
Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke RisksSteve Deitelzweig, Alpesh Amin, Yonghua Jing, et al.
Cutaneous and Ocular Toxicology|March 20, 2014
Beneficial effects of activated macrophages on sulfur mustard-induced cutaneous burns, an in vivo experienceShlomit Dachir, Maayan Cohen, Rita Sahar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
A randomised trial of accelerated radiotherapy for localised invasive bladder cancerAlan Horwich, David Dearnaley, Robert Huddart, et al.
Research in Social & Administrative Pharmacy : RSAP|June 1, 2021
Clinical Judgement Analysis: An innovative approach to explore the individual decision-making processes of pharmacistsJanique Waghorn, Ian Bates, John Graham Davies, et al.
Advances in Experimental Medicine and Biology|June 25, 2020
Fatty Acid Mediators in the Tumor MicroenvironmentSaraswoti Khadge, John Graham Sharp, Geoffrey M Thiele, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 24, 2004
Teenagers' attitudes about coping strategies and help-seeking behavior for suicidalityMadelyn S Gould, Drew Velting, Marjorie Kleinman, et al.
Journal of Medical Economics|March 28, 2012
Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trialsSteve Deitelzweig, Alpesh Amin, Yonghua Jing, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 11, 2013
Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES TrialAlpesh Amin, Steve Deitelzweig, Yonghua Jing, et al.
Journal of Medical Economics|July 23, 2013
Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trialsSteve Deitelzweig, Alpesh Amin, Yonghua Jing, et al.
The American Journal of Managed Care|October 9, 2014
Economic implications of weight change in patients with type 2 diabetes mellitusKelly Bell, Shreekant Parasuraman, Manan Shah, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
Cardiology and Therapy|August 20, 2014
Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke RisksSteve Deitelzweig, Alpesh Amin, Yonghua Jing, et al.
Cutaneous and Ocular Toxicology|March 20, 2014
Beneficial effects of activated macrophages on sulfur mustard-induced cutaneous burns, an in vivo experienceShlomit Dachir, Maayan Cohen, Rita Sahar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
A randomised trial of accelerated radiotherapy for localised invasive bladder cancerAlan Horwich, David Dearnaley, Robert Huddart, et al.
Research in Social & Administrative Pharmacy : RSAP|June 1, 2021
Clinical Judgement Analysis: An innovative approach to explore the individual decision-making processes of pharmacistsJanique Waghorn, Ian Bates, John Graham Davies, et al.
Advances in Experimental Medicine and Biology|June 25, 2020
Fatty Acid Mediators in the Tumor MicroenvironmentSaraswoti Khadge, John Graham Sharp, Geoffrey M Thiele, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 24, 2004
Teenagers' attitudes about coping strategies and help-seeking behavior for suicidalityMadelyn S Gould, Drew Velting, Marjorie Kleinman, et al.
Journal of Medical Economics|March 28, 2012
Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trialsSteve Deitelzweig, Alpesh Amin, Yonghua Jing, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 11, 2013
Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES TrialAlpesh Amin, Steve Deitelzweig, Yonghua Jing, et al.
Journal of Medical Economics|July 23, 2013
Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trialsSteve Deitelzweig, Alpesh Amin, Yonghua Jing, et al.
The American Journal of Managed Care|October 9, 2014
Economic implications of weight change in patients with type 2 diabetes mellitusKelly Bell, Shreekant Parasuraman, Manan Shah, et al.
Pageof 21